BIOMAT Database Logo BIOMAT Database Logo

Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test. 1988

H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Department of Medical Microbiology, University of Wales College of Medicine, Cardiff.

A study programme was set up in Wales and the West Midlands to evaluate serum immunoreactive trypsin screening for cystic fibrosis in neonates using blood spots collected for metabolic screening. By screening half the blood spots from each area, it was hoped to generate two comparable groups of fibrocystic children; those detected by screening and those not screened who would be diagnosed clinically. Over almost three years, more than 120,000 specimens were screened and 37 infants detected with cystic fibrosis. Four additional fibrocystic patients were missed on screening: two had negative immunoreactive trypsin values, of which one had meconium ileus, and two, although giving initial positive tests, were negative on follow up. Excluding infants known to be at risk, comparison of the numbers of children detected in the screened and unscreened groups showed more than a two-fold difference in favour of the screened group. There may be a large number of undiagnosed fibrocystic patients in the general population.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004739 England A part of Great Britain within the United Kingdom.
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005188 False Negative Reactions Negative test results in subjects who possess the attribute for which the test is conducted. The labeling of diseased persons as healthy when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Negative Reaction,Reaction, False Negative,Reactions, False Negative
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin

Related Publications

H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.
January 1991, Archives of disease in childhood,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Immunoreactive trypsin screening for cystic fibrosis.
July 1982, Acta paediatrica Scandinavica,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
June 1981, Clinica chimica acta; international journal of clinical chemistry,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Neonatal infection does not affect the immunoreactive trypsinogen screening test for cystic fibrosis.
July 1994, Journal of pediatric gastroenterology and nutrition,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Immunoreactive trypsin in cystic fibrosis.
January 1984, Journal of pediatric gastroenterology and nutrition,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Evaluation of the Quantase neonatal immunoreactive trypsinogen (IRT) screening assay for cystic fibrosis.
January 2005, Clinical chemistry and laboratory medicine,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Serum immunoreactive trypsin in cystic fibrosis.
January 1980, Scandinavian journal of gastroenterology. Supplement,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Serum immunoreactive trypsin in cystic fibrosis.
January 1981, Thorax,
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
Immunoreactive pancreatic lipase test for neonatal detection of cystic fibrosis.
January 1984, Lancet (London, England),
H C Ryley, and S M Deam, and J Williams, and M Alfaham, and P H Weller, and M C Goodchild, and R A Carter, and D Bradley, and J A Dodge
The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood.
July 1992, Annals of clinical biochemistry,
Copied contents to your clipboard!